Common Contracts
13 similar Underwriting Agreement contracts by Protea Biosciences Group, Inc., Vs MEDIA Holdings LTD, Aditxt, Inc., others
CREATIVE GLOBAL TECHNOLOGY HOLDINGS LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • April 26th, 2024 • Creative Global Technology Holdings LTD • Wholesale-computers & peripheral equipment & software • New York
NEW CENTURY LOGISTICS (BVI) LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • April 16th, 2024 • New Century Logistics (BVI) LTD • Arrangement of transportation of freight & cargo • New York
VS MEDIA HOLDINGS LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • October 2nd, 2023 • Vs MEDIA Holdings LTD • Miscellaneous publishing • New York
VS MEDIA HOLDINGS LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • August 11th, 2023 • Vs MEDIA Holdings LTD • Miscellaneous publishing • New York
Alpha Technology Group Limited UNDERWRITING AGREEMENTUnderwriting Agreement • August 10th, 2023 • Alpha Technology Group LTD • Services-computer programming services • New York
ALE GROUP HOLDING LIMITED UNDERWRITING AGREEMENTUnderwriting Agreement • May 10th, 2023 • ALE Group Holding LTD • Services-management consulting services • New York
ADITXT, INC. UNDERWRITING AGREEMENT October 18, 2021Underwriting Agreement • October 20th, 2021 • Aditxt, Inc. • Pharmaceutical preparations • New York
The undersigned, Aditxt, Inc., a corporation formed under the laws of the state of Delaware (the “Company”), hereby confirms its agreement (this “Agreement”) with Revere Securities, LLC (hereinafter referred to as “you” (including its correlatives) or the “Representative”) and with the other underwriters named on Schedule 1 hereto for which the Representative is acting as representative (the Representative and such other underwriters being collectively called the “Underwriters” or, individually, an “Underwriter” and to the extent there is only a single Underwriter, the term “Underwriters” shall be deemed to refer to the single Underwriter, mutatis mutandis) as follows:
INTERPACE DIAGNOSTICS GROUP, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • June 13th, 2017 • Interpace Diagnostics Group, Inc. • Surgical & medical instruments & apparatus • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • July 15th, 2016 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • June 22nd, 2016 • Protea Biosciences Group, Inc. • Pharmaceutical preparations • New York
UNDERWRITING AGREEMENTUnderwriting Agreement • May 2nd, 2016 • Phaserx, Inc. • Pharmaceutical preparations • New York
Ordinary Shares (No Par Value) MAPI - PHARMA LTD. UNDERWRITING AGREEMENTUnderwriting Agreement • February 1st, 2016 • Mapi - Pharma LTD • Pharmaceutical preparations • New York
Mapi - Pharma Ltd., a corporation incorporated under the laws of the state of Israel (the “Company”), proposes to issue and sell to the several Underwriters named in Schedule I hereto (the “Underwriters”) an aggregate of [____] authorized but unissued Ordinary Shares, no par value, of the Company (the “Firm Shares”).
2,100,000 Ordinary Shares (NIS 1.00 par value) STARLIMS Technologies Ltd. UNDERWRITING AGREEMENTUnderwriting Agreement • May 22nd, 2007 • STARLIMS Technologies LTD • Services-prepackaged software • New York
STARLIMS Technologies Ltd., a company incorporated under the laws of the State of Israel (the “Company”), confirms its agreement with Oppenheimer & Co. Inc. (“Oppenheimer”) and each of the underwriters named in Schedule I hereto (collectively, the “Underwriters”), for whom Oppenheimer is acting as the representative (in such capacity, referred to herein as the “Representative”), with respect to the issue and sale by the Company, and the purchase by the Underwriters, acting severally and not jointly, of 2,100,000 ordinary shares, NIS 1.00 par value per share (“Ordinary Shares”). Such Ordinary Shares are hereinafter referred to as the “Firm Shares.”
